Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have Crohn's disease affecting the small intestine (ileum) or both the small intestine and part of the large intestine, and who need surgery for the first time to remove the affected section.
- People aged 18 years or older, both male and female.
- People with any type of Crohn's disease pattern — including the non-narrowing type, the narrowing type, or the type that causes tunnels or passages to form between organs.
- People who are taking any medications before surgery, including medicines that block a substance called TNF (a type of anti-inflammatory treatment).
Who may not be able to join:
- People under 18 years of age.
- People who have had Crohn's disease surgery before and the disease has come back.
- People who are pregnant.
- People who have more than one separate area of active disease in the bowel, meaning they would need more than one surgical procedure at the same time.
- People whose Crohn's disease extends into the first part of the large intestine (the cecum and ascending colon).
- People who are expected to need ongoing preventive medical treatment after surgery.
- People whose planned surgical procedure needs to be changed once the surgeon examines the inside of the abdomen during the operation.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Fabrizio Michelassi, MD, Weill Medical College of Cornell University
Phone: 646-962-2342
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Post-operative endoscopic remission of Crohn's disease between 3 and 6 months after surgery; Number of subjects with surgical recurrence at 60 months; Number of subjects with surgical recurrence at 120 months; Mucosal Healing GHS; Mucosal Healing IBD-DCA; Surgical Pathology Margins
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.